₹25
▼ -0.12 -0.48%
As of 28 Jul 2026 · delayed
BSE Listed
Kabra Drugs Ltd. (524322)
Volume: 1,38,037Avg Vol 1W: 1,27,764Avg Vol 1M: 1,03,40952W Range:₹15.5₹35.52
Key Ratios
Checked 7h agoMarket Cap₹60 Cr
Current Price₹25
Previous Close₹25.12
High / Low (52w)₹35.52 / ₹15.5
Volume1,38,037
Avg Vol (1W)1,27,764
Avg Vol (1M)1,03,409
Stock P/E12.15
Book Value₹12.49
Dividend Yield0%
ROE16.75%
ROA5.76%
Revenue (TTM)—
Revenue Growth—
Profit Margin5.36%
Total Debt—
Shares Outstanding2 Cr
Face Value—
EPS (TTM)₹2.09
P/B2.03
Debt / Equity0.08
50 DMA₹23.3
200 DMA₹25.89
Day change-0.48%
Price Chart
₹25▲ 25.25% · 1Y
2025-07-292026-07-28
20-day avg volume: 1.0L shares
Pros
- Healthy return on equity of 16.8%.
- Company is almost debt-free.
Cons
- Company is loss-making at the latest annual result.
Quarterly Results
| Metric | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹7 Cr | ₹20 Cr | ₹30 Cr | ₹35 Cr |
| EBITDA | ₹-1 Cr | ₹0 Cr | ₹-1 Cr | ₹0 Cr | ₹0 Cr | ₹2 Cr | ₹3 Cr | ₹1 Cr |
| Net Profit | ₹-1 Cr | ₹0 Cr | ₹-1 Cr | ₹0 Cr | ₹0 Cr | ₹2 Cr | ₹3 Cr | ₹1 Cr |
| EPS | — | — | — | — | — | — | — | — |
Profit & Loss (Annual)
| Metric | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹2 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹1 Cr |
| EBITDA | ₹-1 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹-1 Cr | ₹-1 Cr |
| Net Profit | ₹-2 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹-1 Cr | ₹-1 Cr |
| EPS | -5.37 | -0.38 | -0.14 | -0.41 | -0.42 | -0.77 | -1.68 | -0.99 |
Balance Sheet
| Metric | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | ₹2 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹5 Cr | ₹25 Cr |
| Total Liabilities | ₹2 Cr | ₹1 Cr | ₹1 Cr | ₹2 Cr | ₹1 Cr | ₹1 Cr | ₹3 Cr | ₹1 Cr |
| Equity | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹-1 Cr | ₹1 Cr | ₹25 Cr |
| Total Debt | — | — | — | — | — | — | — | — |
Cash Flow
| Metric | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|
| Operating | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹-5 Cr |
| Investing | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| Financing | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹3 Cr | ₹23 Cr |
| Free Cash Flow | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹-5 Cr |
Shareholding
Promoter 0% Institutions 0% Public 100%
Efficiency & Working Capital
ROCE19.1%
Interest Coverage0
Dividend Payout—
Debtor Days—
Inventory Days—
Payable Days—
Cash Conversion Cycle—
Working Capital Days—
Shareholding Details
As of 2026-06-30
Promoter0%
FII0%
DII0%
Institutions0%
Public100%
Promoter Pledge—
No. of Shareholders9,680
Shareholding Pattern
Quarterly — figures in %. Latest 12 quarters.
| Period | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| FIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| DIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 100% | 100% | 100% | 100% | 100% | 100% | 100% | 100% | 100% | 100% | 100% | 100% |
| Promoter Pledge | — | — | — | — | — | — | — | — | — | — | — | — |
| No. of Shareholders | 7,415 | 7,396 | 7,364 | 7,336 | 7,367 | 7,343 | 7,435 | 7,449 | 8,098 | 8,862 | 9,185 | 9,680 |
Returns History (ROE / ROCE / ROA)
| Period | ROE | ROCE | ROA | P/E |
|---|---|---|---|---|
| 202503 | — | — | — | — |
Major Shareholders (>1%)
| Name | Category | Stake | Shares |
|---|---|---|---|
| Kuniamuthur Nanjappan Anand | Public Shareholding | 2.8% | 6,58,500 |
| Somisetty Malathi Latha | Public Shareholding | 2.2% | 5,27,318 |
| Somisetty Giridhar Gupta | Public Shareholding | 2.1% | 5,02,411 |
| Veeramreddy Vijay Kumar Reddy | Public Shareholding | 1.9% | 4,59,463 |
| Chandraprakash Jamnalal Kabra | Public Shareholding | 1.7% | 4,00,000 |
| Priyam Sachdeva | Public Shareholding | 1.4% | 3,37,184 |
| Adusumilli Sai Raghava Pratap | Public Shareholding | 1.4% | 3,23,232 |
| Narendra Babu Veerla | Public Shareholding | 1.3% | 2,98,930 |
| Akilandeswari Selvamurthy | Public Shareholding | 1.2% | 2,91,816 |
| Priyam Samir Shah | Public Shareholding | 1.2% | 2,76,125 |
| Akansha Gupta | Public Shareholding | 1.1% | 2,52,437 |
| Neha Sagar Shah | Public Shareholding | 1.1% | 2,50,000 |
| Bosco Armando Menezes | Public Shareholding | 1.1% | 2,50,000 |
| Shiva Kumar Adepu | Public Shareholding | 1.1% | 2,49,551 |
| Rathna Pathengay | Public Shareholding | 1% | 2,40,496 |
Board of Directors
| Name | Designation | Year |
|---|---|---|
| N Aravind | Executive Director & MD | 2025 |
| Venkatakrishnappa Ananth Kumar | Executive Director / Whole Time Director / CFO | 2025 |
| KUNIAMUTHUR NANJAPPAN ANAND | Executive Director | 2025 |
| Ananthkumar Shilpa | Independent Director | 2025 |
| A Anitha | Independent Director | 2025 |
| Monika Sanwal | Company Sec. & Compli. Officer | 2025 |
Segments — Product
| Segment | Revenue | Share |
|---|---|---|
| Manufacturing of Drugs | ₹8 Cr | 100% |
Capital Structure (₹ Cr)
| Year | Face Value | Authorised | Issued | Paid-up |
|---|---|---|---|---|
| 2025 | ₹10 | 40 | 24 | 24 |
Related-Party Transactions (₹ Cr)
| Year | Subsidiaries | Associates | JV | KMP | Others | Total |
|---|---|---|---|---|---|---|
| 2025 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2025 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2025 | 0 | 0 | 0 | 0 | 0 | 0 |
Company Information
🌐 www.kabradrugs.com ↗
📍 270 Shastri Market Indore, Indore, Madhya Pradesh, 452007
Technical AnalysisPremium
Technical analysis (Premium)
Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.
More stocks
Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search